Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin Analogs
Bruno Rizzuti, Fedora Grande, Filomena Conforti, et al.
Biomedicines (2021) Vol. 9, Iss. 4, pp. 375-375
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

The SARS‐CoV‐2 main protease (Mpro): Structure, function, and emerging therapies for COVID‐19
Qing Hu, Yuan Xiong, Guanghao Zhu, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 144
Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review
Xin Li, Yongcheng Song
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115772-115772
Open Access | Times Cited: 51
Natural flavonols: actions, mechanisms, and potential therapeutic utility for various diseases
Aar Rafi Mahmud, Tanzila Ismail Ema, Mohd. Faijanur - Rob Siddiquee, et al.
Beni-Suef University Journal of Basic and Applied Sciences (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 40
Inhibition of the SARS-CoV-2 3CLpro main protease by plant polyphenols
Miha Bahun, Marko Jukič, Domen Oblak, et al.
Food Chemistry (2021) Vol. 373, pp. 131594-131594
Open Access | Times Cited: 95
Perspectives on SARS-CoV-2 Main Protease Inhibitors
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 23, pp. 16922-16955
Open Access | Times Cited: 93
Health benefits and limitations of rutin - A natural flavonoid with high nutraceutical value
Ruchi Badoni Semwal, Sunil K. Joshi, Ruchi Badoni Semwal, et al.
Phytochemistry Letters (2021) Vol. 46, pp. 119-128
Closed Access | Times Cited: 92
Calendulaglycoside A showing potential activity against SARS-CoV-2 main protease: Molecular docking, molecular dynamics, and SAR studies
Ahmed A. Zaki, Ahmed Ashour, Sameh S. Elhady, et al.
Journal of Traditional and Complementary Medicine (2021) Vol. 12, Iss. 1, pp. 16-34
Open Access | Times Cited: 89
Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
Ridhima Kaul, Pradipta Paul, Sanjay Kumar, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11069-11069
Open Access | Times Cited: 76
Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the In-Silico World
Muhammad Fayyaz ur Rehman, Shahzaib Akhter, Aima Iram Batool, et al.
Antibiotics (2021) Vol. 10, Iss. 8, pp. 1011-1011
Open Access | Times Cited: 64
Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of Mpro and Its Antiviral Activity in Cells against SARS-CoV-2
Francesca Mangiavacchi, Paweł Botwina, Elena Menichetti, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7048-7048
Open Access | Times Cited: 58
In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2
Seyyed Sasan Mousavi, Akbar Karami, Tahereh Movahhed Haghighi, et al.
Molecules (2021) Vol. 26, Iss. 18, pp. 5724-5724
Open Access | Times Cited: 54
Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial
Amjad Khan, Somia Iqtadar, Sami Ullah Mumtaz, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 38
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial
Francesco Di Pierro, Amjad Khan, Somia Iqtadar, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 32
Discovery of Natural Bisbenzylisoquinoline Analogs from the Library of Thai Traditional Plants as SARS-CoV-2 3CLPro Inhibitors: In Silico Molecular Docking, Molecular Dynamics, and In Vitro Enzymatic Activity
Nopawit Khamto, Kraikrit Utama, Suriya Tateing, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 7, pp. 2104-2121
Closed Access | Times Cited: 24
Molecular simulations of proteins: From simplified physical interactions to complex biological phenomena
Bruno Rizzuti
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2022) Vol. 1870, Iss. 3, pp. 140757-140757
Closed Access | Times Cited: 27
Anti-Entry Activity of Natural Flavonoids against SARS-CoV-2 by Targeting Spike RBD
Jieru Meng, Jiazheng Liu, Lu Fu, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 160-160
Open Access | Times Cited: 17
Therapeutic implications of quercetin and its derived-products in COVID-19 protection and prophylactic
Wan‐Yi Ho, Zi-han Shen, Yijing Chen, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30080-e30080
Open Access | Times Cited: 5
Fabrication of Highly Fluorescent Nitrogen and Phosphorus Dual‐Doped Carbon Dots for Selective Sensing of Rutin
Reham E. Kannouma, Amira H. Kamal, Mohamed A. Hammad, et al.
Luminescence (2025) Vol. 40, Iss. 1
Closed Access
Tea Catechins in Green Tea Inhibit the Activity of SARS-CoV-2 Main Protease via Covalent Adduction
Yoji Kato, Sakiko Suzuki, Akari Higashiyama, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Nanotechnology Applications of Flavonoids for Viral Diseases
Khoshnur Jannat, Alok Kumar Paul, Tohmina Afroze Bondhon, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1895-1895
Open Access | Times Cited: 33
Ethnobotanical Uses, Phytochemistry, Toxicology, and Pharmacological Properties of Euphorbia neriifolia Linn. against Infectious Diseases: A Comprehensive Review
Arifa Sultana, Md. Jamal Hossain, Md Ruhul Kuddus, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4374-4374
Open Access | Times Cited: 22
Anti-SARS-CoV-2, antioxidant and immunomodulatory potential of dietary flavonol quercetin: Focus on molecular targets and clinical efficacy
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, et al.
European Journal of Medicinal Chemistry Reports (2023) Vol. 10, pp. 100125-100125
Open Access | Times Cited: 14
Therapeutic Potential of Glycosyl Flavonoids as Anti-Coronaviral Agents
Patrícia I. C. Godinho, Raquel G. Soengas, Vera L. M. Silva
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 546-546
Open Access | Times Cited: 27
Impact of Rutin and Other Phenolic Substances on the Digestibility of Buckwheat Grain Metabolites
Ivan Kreft, Mateja Germ, Aleksandra Golob, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3923-3923
Open Access | Times Cited: 19
The possible therapeutic role of curcumin and quercetin in the early-stage of COVID-19—Results from a pragmatic randomized clinical trial
Ikram Din Ujjan, Saeed Khan, Roohi Nigar, et al.
Frontiers in Nutrition (2023) Vol. 9
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top